AAREYDRUGS — Aarey Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.55bn
- IN₹1.87bn
- IN₹4.74bn
- 52
- 43
- 53
- 48
Annual cashflow statement for Aarey Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 83 | 100 | 60.1 | 53.4 | 61 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 24.3 | 20 | 28.7 | 43.8 | 40.2 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -61.8 | -185 | -117 | -137 | -24.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 54.8 | -44.9 | -12.8 | -29.9 | 96.5 |
| Capital Expenditures | -28.8 | -22 | -10.4 | -7.22 | -52 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.046 | 14.8 | -9.8 | -7.35 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -28.8 | -22 | 4.41 | -17 | -59.4 |
| Financing Cash Flow Items | -24.3 | -20 | -28.7 | -44.3 | -40.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -24.5 | 62.3 | 13.5 | 55.8 | -38.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.47 | -4.58 | 5.14 | 8.89 | -1.21 |